Honey, Gellan Gum, and Hyaluronic Acid as Therapeutic Approaches for Skin Regeneration

<b>Background/Objectives</b>: Chronic wounds pose a significant health concern, with their prevalence increasing due to various etiologies. The global aging population further contributes to this rise, placing a substantial burden on healthcare systems in developed countries. This work aimed to develop new therapeutic options in the form of creams and dressings based on honey, gellan gum, and hyaluronic acid for preventing and treating chronic wounds across all stages. <b>Methods</b>: To address this, after the formulations were developed, in vitro cytocompatibility was determined. To confirm biocompatibility, an ovine wound model was used: full-thickness excisional wounds were treated with three formulations, namely gellan gum and honey sponges (GG-HNY), gellan gum, honey and hyaluronic acid sponges (GG-HA-HNY) and a honey-based cream (cream FB002). Daily assessments, including visual evaluation and wound scoring, were conducted for 30 days. Following the study period, tissues were collected for histological analyses. <b>Results</b>: The macroscopic examination revealed that all therapeutic groups facilitated lesion closure. Lesion size reduction, granulation tissue disappearance, and scar tissue development were consistent across all groups, with the group receiving cream demonstrating an advanced stage of healing. All groups achieved substantial wound closure by day 30, with no significant differences. Histopathological analysis following ISO standards revealed that GG-HA-HNY had the lowest ISO score, indicating minimal reactivity and inflammation, which corroborated the cytocompatibility. <b>Conclusions</b>: Combining these insights with previous findings enhances our understanding of wound regeneration dynamics and contributes to refining therapeutic strategies for chronic wounds. The formulations were designed to balance therapeutic efficacy with cost-effectiveness, leveraging low-cost raw materials and straightforward production methods.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2025-02-18
DOI
https://doi.org/10.3390/biomedicines13020508
Citations
2
Primary Topic
Bee Products Chemical Analysis
Type
article
Field-Weighted Citation Impact
3.34
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Honey, Gellan Gum, and Hyaluronic Acid as Therapeutic Approaches for Skin Regeneration

Patrícia Sousa, Maria Manuel Balça, Bruna Lopes, Lucília P. da Silva et al.
2 citations
Biomedicines
Bee Products Chemical Analysis
3.34
article

Honey, Gellan Gum, and Hyaluronic Acid as Therapeutic Approaches for Skin Regeneration

Patrícia Sousa, Maria Manuel Balça, Bruna Lopes, Lucília P. da Silva, André Coelho, Alexandra P. Marques, F. S. Batista, Rui Alvites, Filipa Mata, Irina Amorim, Ana Catarina Sousa, Luís Atayde, Alícia Moreira, Carla Lopes de Mendonça, Alexandra Rêma, Ana Colette Maurício, Cristiana Costa, João Transmontano
article en
2 citations

Abstract

<b>Background/Objectives</b>: Chronic wounds pose a significant health concern, with their prevalence increasing due to various etiologies. The global aging population further contributes to this rise, placing a substantial burden on healthcare systems in developed countries. This work aimed to develop new therapeutic options in the form of creams and dressings based on honey, gellan gum, and hyaluronic acid for preventing and treating chronic wounds across all stages. <b>Methods</b>: To address this, after the formulations were developed, in vitro cytocompatibility was determined. To confirm biocompatibility, an ovine wound model was used: full-thickness excisional wounds were treated with three formulations, namely gellan gum and honey sponges (GG-HNY), gellan gum, honey and hyaluronic acid sponges (GG-HA-HNY) and a honey-based cream (cream FB002). Daily assessments, including visual evaluation and wound scoring, were conducted for 30 days. Following the study period, tissues were collected for histological analyses. <b>Results</b>: The macroscopic examination revealed that all therapeutic groups facilitated lesion closure. Lesion size reduction, granulation tissue disappearance, and scar tissue development were consistent across all groups, with the group receiving cream demonstrating an advanced stage of healing. All groups achieved substantial wound closure by day 30, with no significant differences. Histopathological analysis following ISO standards revealed that GG-HA-HNY had the lowest ISO score, indicating minimal reactivity and inflammation, which corroborated the cytocompatibility. <b>Conclusions</b>: Combining these insights with previous findings enhances our understanding of wound regeneration dynamics and contributes to refining therapeutic strategies for chronic wounds. The formulations were designed to balance therapeutic efficacy with cost-effectiveness, leveraging low-cost raw materials and straightforward production methods.

BiomedicinesVol. 13(2)
Universidade do Porto (PT), Cooperativa de Ensino Superior Politécnico e Universitário (PT), i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT), University of Minho (PT)
Partnerships for the goals
Openalex Percentile: Top 11%
Bee Products Chemical Analysis
3.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.